Call Options

16 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$2.08 - $2.49 $111,904 - $133,962
53,800 New
53,800 $118,000
Q1 2022

May 17, 2022

SELL
$3.0 - $4.25 $73,800 - $104,550
-24,600 Reduced 10.9%
201,100 $780,000
Q4 2021

Feb 15, 2022

BUY
$3.85 - $6.71 $105,105 - $183,183
27,300 Added 13.76%
225,700 $889,000
Q3 2021

Nov 16, 2021

SELL
$5.6 - $8.58 $1.14 Million - $1.75 Million
-203,600 Reduced 50.65%
198,400 $1.12 Million
Q2 2021

Aug 16, 2021

SELL
$7.16 - $9.41 $1.53 Million - $2.02 Million
-214,200 Reduced 34.76%
402,000 $3.46 Million
Q1 2021

May 18, 2021

BUY
$7.52 - $15.55 $2.29 Million - $4.73 Million
304,400 Added 97.63%
616,200 $5.83 Million
Q4 2020

Feb 17, 2021

SELL
$5.0 - $8.85 $431,500 - $763,755
-86,300 Reduced 21.68%
311,800 $2.16 Million
Q3 2020

Nov 17, 2020

SELL
$4.96 - $7.08 $2.83 Million - $4.03 Million
-569,900 Reduced 58.87%
398,100 $2 Million
Q2 2020

Aug 17, 2020

BUY
$4.84 - $8.02 $3.52 Million - $5.83 Million
727,300 Added 302.16%
968,000 $5.83 Million
Q1 2020

May 15, 2020

BUY
$4.52 - $8.55 $193,455 - $365,940
42,800 Added 21.63%
240,700 $1.37 Million
Q4 2019

Feb 14, 2020

BUY
$6.14 - $9.3 $851,004 - $1.29 Million
138,600 Added 233.73%
197,900 $1.52 Million
Q3 2019

Nov 14, 2019

SELL
$9.05 - $16.02 $584,630 - $1.03 Million
-64,600 Reduced 52.14%
59,300 $536,000
Q2 2019

Aug 15, 2019

SELL
$13.58 - $18.61 $783,566 - $1.07 Million
-57,700 Reduced 31.77%
123,900 $1.99 Million
Q1 2019

May 16, 2019

BUY
$11.31 - $23.7 $800,748 - $1.68 Million
70,800 Added 63.9%
181,600 $3.34 Million
Q4 2018

Feb 15, 2019

SELL
$6.8 - $12.88 $6.83 Million - $12.9 Million
-1,003,700 Reduced 90.06%
110,800 $1.17 Million
Q3 2018

Nov 14, 2018

BUY
$5.65 - $13.75 $6.3 Million - $15.3 Million
1,114,500 New
1,114,500 $12.4 Million

Others Institutions Holding CRON

About Cronos Group Inc.


  • Ticker CRON
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 377,896,000
  • Market Cap $737M
  • Description
  • Cronos Group Inc. operates as a cannabinoid company. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products through e-commerce, retail, and hospitality partner channels under the Lord Jones and Happy Dance brands in the United States. The company is also involved in the cultivation, manufacture, and marketing of...
More about CRON
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.